SNP,effect_allele.exposure,other_allele.exposure,effect_allele.outcome,other_allele.outcome,beta.exposure,beta.outcome,eaf.exposure,eaf.outcome,remove,palindromic,ambiguous,id.outcome,chr,pos,se.outcome,samplesize.outcome,pval.outcome,outcome,mr_keep.outcome,se.exposure,pval.exposure,chr.exposure,samplesize.exposure,pos.exposure,id.exposure,exposure,mr_keep.exposure,pval_origin.exposure,data_source.exposure,action,mr_keep
rs13394970,G,T,G,T,-0.00156276,-0.0324,0.609011,0.592445,FALSE,FALSE,FALSE,ebi-a-GCST002245,2,26929282,0.0161,54162,0.04456,Alzheimer's disease (late onset),TRUE,0.000224297,3.19963e-12,2,462933,26929282,ukb-b-8668,Treatment/medication code: doxazosin || id:ukb-b-8668,TRUE,reported,igd,2,TRUE
rs34071855,G,C,G,C,0.00148721,-8e-04,0.340045,0.353877,FALSE,TRUE,FALSE,ebi-a-GCST002245,1,10798489,0.0168,54162,0.9618,Alzheimer's disease (late onset),TRUE,0.000231644,1.40001e-10,1,462933,10798489,ukb-b-8668,Treatment/medication code: doxazosin || id:ukb-b-8668,TRUE,reported,igd,2,TRUE
rs4980379,T,C,T,C,0.0014007,-0.0168,0.364116,0.389662,FALSE,FALSE,FALSE,ebi-a-GCST002245,11,1888614,0.0172,54162,0.3297,Alzheimer's disease (late onset),TRUE,0.000227723,7.69999e-10,11,462933,1888614,ukb-b-8668,Treatment/medication code: doxazosin || id:ukb-b-8668,TRUE,reported,igd,2,TRUE
rs758374,C,T,C,T,0.00143293,-0.0267,0.304447,0.304175,FALSE,FALSE,FALSE,ebi-a-GCST002245,22,19971552,0.0173,54162,0.1234,Alzheimer's disease (late onset),TRUE,0.000237348,1.6e-09,22,462933,19971552,ukb-b-8668,Treatment/medication code: doxazosin || id:ukb-b-8668,TRUE,reported,igd,2,TRUE
